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A number of antigen-specific T  cell-produced suppressor factors have been reported 
to express I-J-controlled antigenic determinants (1, 2). In most cases, the Ly phenotype 
of the  cell  producing  the  biologically active factors has not  been determined.  One 
factor, studied by Tada and his associates (2), has been shown to come from Ly-1-2  + 
cells and to act in combination with an I-J  + Ly-l,2 cell to amplify Ly-l-2  + suppressor 
cell activity. Another I-J  + factor we have described (3)  is specified for sheep erythro- 
cytes (SRBC) 1 and is made by Ly-l+2  -  I-J  + cells (Ly-1 TsiF). 
The question of how the major histoeompatibility complex (MHC)  gene product 
relates  to the  antigen  specificity of the  factors activity is not  known.  In studies  of 
"factors" secreted by immune T  cells,  no one has as yet succeeded  in separating a 
molecule that expresses an I-J determinant from a molecule that sees antigen. Because 
an  impressive  body  of circumstantial  evidence  has  suggested  that  the  genes  that 
control the antigen specificity of T  suppressor cells are encoded on the  12th chromo- 
some (4) and that the gene that controls the expression of I-J is encoded on the  17th 
chromosome  (5),  an  important  question  remains to be answered:  How do the  two 
products,  I-J and  the  antigen  recognition  unit,  become associated?  Based  on  the 
precedent established from studies of better defined antigen-specific products of the 
immune system (i.e.,  antibodies), covalent linkage by disulfide bonds would seem to 
be the most likely answer to this question. Evidence that such may be the case comes 
from  studies  of T  cell  hybridomas  that  express  antigen-specific  activity,  but  the 
evidence is contradictory. 
Taussig and  Holliman  have shown  (6)  that  an  anti-H-2  serum  will  remove the 
antigen-binding capacity of biosynthetically labeled  material  in  the supernatant  of 
an SRBC-specific suppressive T  hybrid line, but will not do so if the antigen-binding 
* Supported in part by grants CA-08593, CA-29606, CA-14216, and a central resource facility  CA-16359 
from the National Cancer Institute and National Institutes of Health, Bethesda, Md. 
I Abbreviations used in  this paper: BRBC, burro  erythrocytes; FCS, fetal calf serum; HRBC, horse 
erythrocytes; Igh, Ig heavy chain complex; Igh-V or VH, Igh variable region; KLH, keyhole limpet 
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activity comes from NP-40 extracts of the T  hybrid line.  From this data they infer 
that the H-2 determinant and the antigen-binding unit are on two separate polypep- 
tides that are linked when the molecule is secreted. The chemical basis for the inferred 
linkage of the two molecules was not  established,  but  evidence was presented  that 
indicated that the chains were not linked by disulfide bonds. 
More recently, Taniguchi and his associates (7) have obtained interesting relevant 
data with a keyhole limpet hemocyanin (KLH)-specific I-J  + T  cell hybridoma. They 
have shown that in the secreted form, the hybridomas I-J  + marker and the antigen- 
binding moiety travel together on affinity columns, using biological activity as a read- 
out.  These findings are similar to those reported by Benacerraf and co-workers (8). 
Taniguchi et al. have further shown that extracts of the hybridoma presumably made 
by ultrasonication can also have their suppressive activity removed by passage through 
an  antigen  column  or  an  anti-I-J  column.  However,  in  contrast  to  the  secreted 
material, recombination of the materials that do not bind to KLH with those that do 
not  bind to the anti-I-J serum restores the highly suppressive nature of the extract. 
Thus, their evidence suggests that there are two distinct molecules in the extract that 
are synthesized  in  the cytoplasm of the hybridoma and  that  do not  associate until 
they are expressed on the cell's surface or secreted from it.  Because they have been 
able  to  separate  the  secreted  I-J  +  material  from  the  KLH-binding  molecule  by 
treatment  with  5  mM  dithiothreitol,  they suggest  that  the  two  molecules  may be 
disulfide bonded. 
Thus,  in  two  cases  using  different  read-out  methods,  data  have been  presented 
indicating that T  cell hybrids make two separate molecules, one that sees antigen and 
the other that bears H-2 markers, and that these molecules combine in some form of 
tight association when they are secreted from the cells. In neither of these cases was 
the Ly phenotype of the cell that fused with the thymoma cell line determined. 
Studies  with  the  SRBC-specific I-J  +  Ly-1  T  suppressor inducer  factor (Tsil  0  we 
described yield results somewhat different from any of the previous reported results 
using I-J  + antigen-specific T  suppressor factors from either normal or tumorous cells. 
In the supernatants of cultured  immune Ly-1 cells, we find two easily disassociated 
molecules (in fact, they are so easily disassociated that we have no evidence that they 
are ever associated); one of these is I-J  + and does not react with antigen, and the other 
is I-J- and binds the SRBC.  Neither molecule has biological activity on its own, but 
biological activity can be achieved by mixing the two separate molecules. We have 
been  able  to  make "hybrid  molecules" by taking I-J  +  material  from T  suppressor 
inducer cells of one antigen  specificity and  mixing them with  the  antigen-binding 
material  from  T  suppressor  inducer  cells  of a  different  specificity.  These  types  of 
results confirm the separateness of the two molecules required  for biological activity 
and  also confirm the observation  that  the  I-J  + material  has no  antigen  specificity. 
Because the molecule we are studying will not induce suppression in cells that express 
Igh variable region  (VH)  gene-linked polymorphisms that differ from the producer 
cells, we have been able to use these hybrid molecules to ask the question:  Which of 
the two molecular components used to make the suppressor inducer molecule biolog- 
ically active imparts the VH-linked restriction? Interestingly and surprisingly, it is the 
I-J  + antigen nonbinding molecule that acts as the restricting element. The genotype 
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it is combined with an I-J  + chain from a mouse expressing the appropriate VH-linked 
gene, antigen-specific suppressive induction occurs. 
Materials and Methods 
Mice.  C57BL/6 and  BALB/c  mice, 6-10 wk of age,  were obtained from  The Jackson 
Laboratory, Bar Harbor, ME. CB.20,  BALB.B, and BC.9 mice were raised in the Yale animal 
facility with the help of C. A. Janeway, Yale University, New Haven, CT. 
Antigens.  SRBC, horse erythrocytes (HRBC), and burro erythrocytes (BRBC) were obtained 
from Colorado Serum Company Laboratories, Denver, CO. 
Production and  Use  of Antisera.  Monoclonal anti-Ly-l.2 and  anti-Ly-2.2 were  generously 
supplied by F. W. Shen, Sloan-Kettering Memorial Institute, New York. Anti-t-J  b serum was 
prepared  by  D.  B.  Murphy by hyperimmunizin~g B10.A(5R)  recipients with  a  mixture of 
B10.A(3R)  spleen and lymph node cells. Anti-I-J  serum was kindly provided by Dr. Chella 
David. The specificity of the anti-I-J  b serum was established in two ways:  (a) absorption of the 
serum with B 10.A(3R)  and not B 10.A(5R)  removed eytotoxic activity against I-J  b  cells that 
participate in the "feedback suppressor circuit" (3);k  (b) the anti-I-J  b immunoabsorbents (see 
below for method of preparation) did not absorb I-J  or I-J  a Ly-1 TsiF. The specificity of the 
anti-I-J  d serum was tested only in the second way (e.g., on the immunoabsorbents). 
The spleen cells, which were the source of the Ly-1 TsiF, were treated with anti-Ly-2.2 serum 
in the  following manner:  1 ×  10  v spleen cells/ml were incubated in appropriately diluted 
antisera on ice for 45  rain, centrifuged, and then resuspended in a  1:5  dilution of rabbit 
complement (C') that had been prescreened for low background cytotoxicity. After incubation 
at 37 ° for 30 min, the cells were washed twice in balanced salt solution (BSS) and resuspended 
in tissue culture media that was RPMI 1640 su~oplemented with 10% fetal calf serum (FCS), 
100 mM L-glutamine, 25 mM Hepes, 5 ×  10-  M, 2-mercaptoethanol, and antibiotics. The 
adequacy of the antiserum treatments was established by showing that none of the suppressive 
factor made in the cultures had Ly-2 TsF-like activity, i.e., they were not H-2 restricted and 
could not suppress Ly-2-depleted spleen cells (9). 
Production of the Ly-l-derived  Suppressor Inducer Material  (Ly-1  TsiF).  Mice were immunized 
intraperitoneally  with 0.2 ml of 20% SRBC twice, at an interval of 2 wk. They were killed 2 wk 
after the second immunization. A suspension of their spleen cells was treated with anti-Ly-2 
and rabbit C' as described above and then cultivated in vitro for 48 h at a concentration of 1 
×  10  v cells/ml of RPMI 1640 supplemented with 10% FCS in a CO2 incubator. After 48 h of 
cultivation, supernatant fluids were harvested, centrifuged at 2,500 rpm for 20 min, and passed 
through millipore filters. Although no antigen was added to the factor(s)  producing cells during 
the  48-h  incubation period,  it  is possible that  small amounts of residual antigen from the 
previous immunizations were carried over into the culture. The need for antigen induction in 
vitro to get factor production is presently under investigation. Previous studies (3) have shown 
that Ly-1 cells actually produced the factor by the use of cells that were selected on an anti-Ly- 
1-coated  dish and were 95-98% Ly-1 +, as judged by ~mmunofluoreseence  as a source of factor. 
Absorption of Soluble Factor.  For absorption with RBC,  1 ml of supernatant material was 
mixed with 0.1 ml of a 50% suspension of erythrocytes for 1 h on ice and then centrifuged. For 
other absorptions, supernatants were passed over immunoabsorbents  prepared by conjugation 
of antisera to cyanogen bromide-activated Sepharose using the method of Axen et al. (10). We 
appreciate the help of G. Michael Iverson in preparing these columns. 
In  Vitro Prima~y Anti-RBC Response.  A modification of the cell culture technique described 
initially by Mishell and Dutton (11) was used to generate in vitro primary anti-RBC (sheep 
and horse)  response.  Unprimed spleen cells were cultured with a  concentration of 5 xlO  e 
cells/ml of culture media in Linbro (Linbro Chemical Co.,  Hamden, CT.) 24 flat-bottomed 
dishes at 37°C in a 5% COz incubator with 0.1  ml of 0.4% RBC for 5 d. Plaque-forming cell 
(PFC) responses were determined by Cunningham's modification of the Jerne plaque assay 
(12). The mean and standard error of PFC were calculated from triplicate cultures. The various 
Ly-1 TsiF materials were added to assay cultures at the time of initiation at a final dilution of 
1:10. When recombination  of separated macrornolecules that compose the Ly-1 TsiF were done, 
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Results 
Separation  of the  Antigen-binding  and  the  I-J + Molecules by  Absorption Studies.  The 
supematants  from  the  48-h  cultures  of  immunized  Ly-1  cells  (Ly-1  TsiF)  were 
fractionatd by their antigen-binding capacity or by their ability to stick to anti-I-J 
immunoabsorbent  columns.  Neither the filtrate coming through an I-J column, nor 
the eluate from that column, nor the material left after antigen absorption, had any 
suppressive capacity on  the primary response  to  SRBC  in  Mishell-Dutton cultures 
(Table  I).  Recombination  experiments  showed  that  both  the  filtrate  from  the  I-J 
column and the material left after antigen absorption could reconstitute suppressive 
activity when added to the I-J eluate; however, mixing the antigen filtrate with the 
I-J eluate did not reconstitute activity. Thus, the material eluted from the I-J column 
and  the material left after antigen absorption displayed similar properties, whereas 
the  material  eluted  from  the  I-J  column  was  different.  The  most  straightforward 
interpretation of these data is that  the I-J eluate and the antigen filtrate contained 
the same molecule that did not have the capacity to recognize antigen. The I-J filtrate 
contained  a  separate  molecule  that  could  see  antigen,  and  both  molecules  were 
required for the expression of biological activity. 
We did two types of exeriments to test this conclusion; in one set of experiments we 
absorbed  the  filtrate  and  the  eluate  with  specific  antigen  to  see  which  molecule 
recognized the antigen; the results of such an experiment (Table II) show that antigen 
can absorb all the biological activity from the I-J filtrate but not the I-J eluate. Thus, 
this experiment confirms two of the conclusions drawn from the experimental data in 
Table I: (a) two separate molecules are required for biological activity, and (b) the I- 
J-  molecule is antigen-specific and the I-J  + molecule is not. 
Separation of the Molecule That Confers Antigen Specificity from the I-J + Molecules by Doing 
Factor Reconstitution Studies.  To  further  test  the conclusions  drawn  from  absorption 
TABLE  I 
Biological Activity of Ly-1 TsiF Is Dependent on Two Separate Molecules 
Source of Ly-I TsiF  B6 spleen cells 
I-j  I-j  Antigen  Experi-  Experi- 
filtrate*  eluate*  filtrate*  ment  1  ment 2 
Comments 
PFC/culture 
-  -  -  1,900  2,300 
+  -  -  1,900  2,700 
-  +  -  1,600  2,200 
-  -  +  2,300  ND:[: 
+  +  -  600  400 
+  -  +  800  ND 
-  +  +  2,100  ND 
Control response 
No suppression: all three treatments  inacti- 
vate factor 
Suppression:  I-J eluate or antigen  filtrate 
can give I-J filtrate suppressive activity 
No suppression: I-J eluate and antigen  fil- 
trate do not reconstitute suppression 
The conclusions are as follows. I-J eluate and antigen  filtrate are molecule 1. I-J filtrate is molecule 2. 
Molecule 1 is nonantigen  binding; molecule 2 binds antigen. 
* See Materials and Metods for details of how these separation techniques were performed and for dose of 
material added to cultures. 
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TABLE II 
I-J + Molecule in Ly-I TsiF Molecular Complex Does Not Bind Antigen; the 
I-J- Molecule Does (Absorption) 
Source of Ly- 1 TsiF 
I-j filtrate*  I-J eluate* 
B6 spleen 
cells 
PFC/ culture 
-  -  1,100 
+  -  1,100 
-  +  900 
+  +  300 
+  (antigen absorbed):~  +  1,000 
+  +  (antigen absorbed):~  300 
* See Materials and Methods  for details of how these separation  techniques 
were performed and for dose of material added to cultures. 
:~ Absorbed with SRBC (see Materials and Methods). 
TABLE  III 
I-J Molecule in Ly-I TsiF Molecular Complex Does Not Have Antigen 
Specificity; the I-J- Molecule Does (Reconstitution) 
Source of Ly- 1 TsiF  B6 spleen cells 
I-J filtrate*  I-J eluate*  SRBC:~  HRBC§ 
P  FC  /culture 
1,200  1,800 
SRBCII  SRBC  700  2,200 
SRBC  HRBC  450  3,100 
HRBC  HRBC  ND¶  800 
HRBC  SRBC  1700  800 
* See footnote, Table I. 
:i: Primary in vitro response to SRBC. 
§ Primary in vitro response to HRBC. 
[I Antigen used to immunize factor producing mice. 
¶ Not done. 
studies, we did a  series of experiments making hybrid molecules in which we mixed 
the I-J filtrate and the I-J eluate of Ly- 1 TsiF factors that were specific for different 
heterologous  erythrocytes.  The  results  of  two  of  these  types  of  experiments  are 
presented in Tables III and IV. The experiment shown in Table III used Ly-1 TsiF 
from  SRBC  and HRBC-immune  Ly-1 cells. The results show that the specificity of 
the factors comes from the material in the I-J filtrate; the material in the I-J eluate 
will reconstitute the specific suppressive activity of both SRBC  and HRBC  antigen- 
binding molecules with equal efficiency. The results in Table IV come from the same 
type of experiment using BRBC cells in place of HRBC cells and yields the same type 
of data. That  is,  (a)  the I-J eluate has  no  antigen specificity, (b)  it can  reconstitute 
biological  activity  of  I-J  filtrates,  and  (c)  such  reconstituted  factors  express  the 
specificity of the I-J filtrate (i.e., the molecule that  determines antigen specificity is 
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TABLE IV 
I-J + Molecule in Ly-1  TsiF Molecular Complex Does Not Have Antigen 
Specificity; the I-J- Molecule Does (Reconstitution) 
Source of Ly-1 TsiF 
I-J filtrate*  l-J eluate* 
B6 spleen cells 
Experiment  Experiment 
1  2 
SRBC~  BRBC§  SRBC~ 
PFC/  culture 
2,900  1,400  1,400 
SRBCII  SRBC  700  1,200  400 
SRBC  BRBC  700  1,300  350 
BRBC  BRBC  2,700  500  1,300 
BRBC  SRBC  1,900  540  1,000 
* See footnote, Table I. 
Primary in vitro response to SRBC. 
§ Primary in vitro response to HRBC. 
[I Antigen used to immunize factor producing mice. 
The I-J + Molecule  That Does Not Bind Antigen Is Responsible for the  VII Restriction of the 
Factor's  Biological  Activity.  Having shown  that  molecules  from different  factors can 
reconstitute  biological  activity  and  that  the  molecule  that  is  I-J-  imparts  antigen 
specificity,  we  were  now  able  to  ask  the  important  question:  Which  of the  two 
molecules  was  responsible  for  the  VH-linked  restriction  that  the  intact  Ly-1  TsiF 
suppressor  molecule showed?  The  results  of a  series  of experiments  using  immuno- 
globulin  (Igh) and  H-2 congenic mice to supply one of the two necessary molecules 
(Table  V)  showed  that  the  I-J  +  molecule  and  not  the  antigen-binding  one  had  to 
come from cells that expressed the same polymorphisms in the Igh complex as did the 
assay cells for suppression to be seen. The easiest way to decipher the data that allows 
this conclusion is to note that in all cases where the cellular source of the I-J  + molecule 
is identical at the Igh complex with the B6 acceptor cells (identified by a +  marker in 
the appropriate  Ig column; the one with an asterisk)  there is significant suppression 
except  for the control experiment  in which there  was no antigen-binding  molecule 
because  of antigen  absorption  (experiment  5).  Note  the  contrast  in  experiment  5, 
where antigen absorption of the I-J eluate  did not remove suppressive activity. This 
finding indicates  that  no contaminant  antigen-binding  material  was present  in  the 
reconstituting I-J  + eluate.  In all other columns, one can note that suppression  takes 
place when  (-)  markers are present, showing the irrelevancy of (a)  H-2 haplotype in 
either molecule and  (b)  Ig haplotype in the antigen-binding molecule. 
Discussion 
The  notion  of interactions  between  products  of  Ig  gene  complexes  forms  the 
foundation on which network theories  are built  (13).  It has been presumed that  the 
antigen-specific molecules carry the determinants  that are involved in idiotype anti- 
idiotype  regulatory reactions.  Our results  show  that  at  least  in one case  this  is  not 
true. There is an immunoregulatory T  cell fator (3)  that contains a  distinct  molecule 
that  interacts  with VH gene-controlled products and  that  does not see antigen  (the YAMAUCHI  ET  AL.  661 
TABLE  V 
Antigen Nonbinding 1-,]  + Molecule Contains Igh- (or Anti-Igh)-linked  Cell Interaction Molecule; Antigen- 
binding Molecule Not Involved in Igh-restricted Interaction (Studies with BAB. 14. Mice Map the Igh 
Restriction to Igh- V [3]) 
Source of antigen binding 
molecule*  Source of I-J + molecule 
B6 
Identity  spleen  Suppres-  Experiment  Mouse  Identity with assay  Mouse strain  with assay  sion 
number  strain  cells  cells 
cells 
Ig*  H-2:~  Ig~§  H-2* 
PFC/  culture 
None  None  1,400  Standard 
None  B6 II  0  0  1,200  - 
B6  +  +  B6  +  +  400  + 
BALB.B  I  -  +  B6  +  +  300  + 
None  None  2,800  Standard 
None  CB20**  0  0  4,000  - 
CB20  +  -  CB20  +  -  900  + 
CB20  +  -  BALB/c:~:~  -  -  3,200  - 
BALB/c  -  -  CB20  +  -  400  + 
None  None  1,900  Standard 
B6  +  +  BALB.B  -  +  2,200  - 
BALB.B  -  +  B6  +  +  400  + 
None  None  1,900  Standard 
B6  +  +  BC.9§§  --  +  2,300  - 
BC.9  -  +  B6  +  +  800  + 
None  None  4,200  Standard 
B6  +  +  BC.9  ~  +  3,200  - 
BC.9  -  +  B6  -4-  -4-  1,000  -4- 
BC.9IIII  -  +  B6  +  +  4,700  -11 
BC.9  -  +  B6[Ill  +  +  1,400  + 
* See footnote, Table I. 
:l: (+),  homology with  B6 assay cells;  (-),  no homology;  (0),  no antigen-binding chain added  (i.e., 
control). 
§ This column identifies key molecule that imparts VH restriction. 
II n-2b; Ig~. 
I  H-2b; Ig  ~. 
** H.2d; Ig  b. 
~* H-2d;  Ig'. 
§§ H-2b; Ig'. 
Illl Absorbed with SRBC (see Materials and Methods). 
11 No suppression due  to  lack of antigen-binding molecule.  (0),  no  antigen-binding chain added  (i.e., 
control). 
genetic  mapping  done  in  the  studies  presented  in  this  paper  does  not  distinguish 
between  VH-  and  CH-controlled  interactions,  but  previous  studies  (3) with  this factor, 
using  the  crossover  in  BAB.14  mouse,  have  shown  that  the  relevant  structures  are 
controlled  by  VH).  If  one  wishes  to  maintain  a  strict  network  theory  of  immuno- 
regulation,  one  could  hypothesize  that  the  molecule  that  fails  to  see antigen  is anti- 662  MOLECULAR  COMPOSITION OF  LY-1 T  SUPPRESSOR INDUCER FACTOR 
idiotype  and  thus  sees  idiotype  on  the  cell  with  which  it  interacts.  (Because  the 
molecule does not see antigen, it would be like the Ab3 (anti-anti-idiotype) in network 
terminology  [14]),  with  one  major  exception:  this  particular  Ab3  bears  a  marker 
controlled by genes on the  17th chromosome (e.g., I-J). 
However, because the factor has no biological activity without an accompanying 
molecule that does see antigen, a  role for the antigen-recognizing molecule must be 
found. If the function of the antigen-binding molecule is to focus the factor on the 
appropriate target cell via an antigen bridge (which seems likely), then the tables are 
turned,  and  a  novel  role  for  the  I-J  +  anti-idiotype  molecule  must  be  found.  It  is 
possible  that  two  focusing events  are  required  to  bring  the  two  molecules  to  the 
appropriate  cells,  and  then  biological  function is  brought  about  by an  interaction 
between  the  two  molecules  on  the  cell  surface,  perhaps  in  a  way  similar  to  the 
activation of zymogens by proteases. Alternatively, the two molecules may not come 
together but may act on different  cells.  Whatever roles the two molecules play, the 
importance  of  the  findings  is  that  it  gives  equality  if  not  primacy  to  antigen- 
recognizing molecules (as opposed to "Igh-encoded idiotype-recognizing antibodies") 
in immune regulation. 
It is clear that our studies cannot formally rule out a partial role of a network type 
interaction,  as  there  is  sufficient  plasticity  in  the  theory  that  would  allow  it  to 
accommodate our findings using either the ad hoc assumptions mentioned above or 
others. However, we find the data so similar to that generated in studies (15) ofT cell 
dual  recognition, where MHC-controlled determinants are the restricting elements, 
to make us favor an alternate explanation for the data.  We suggest that domains of 
the antigen-binding units on some T  cells  (or on closely associated structures) express 
gene products that are homologous to some products of the MHC and act as classical 
cell  interaction  structures  as  originally  enunciated  by  Katz  and  Benacerraf  (16). 
Interestingly, the cell interaction structures they defined act as potent transplantation 
antigens.  It  should  therefore  be  recalled  that  transplantation  antigens  have  been 
found (by genetic backcross studies) to be tightly linked to the Ig heavy chain complex 
(17,  18). Our guess would be that these are the type molecules that are involved in the 
VH anti-VH interactions and that are required for biological activity of the factor we 
have described. If this is true and we can show that both the antigen binding and the 
I-J  + molecule act on the same cell, then our model would unambiguously show a case 
where dual recognition is required for biological activity. Altered self recognition on 
its  own cannot explain  our results  because the specific antigen-binding molecule is 
absolutely required for biological function. 
The intriguing question that remains to be answered is: Why is a product controlled 
by a  gene on the  17th chromosome (I-J) a  marker for a  molecule that interacts with 
another  molecule  controlled  by  a  gene  product  on  the  12th  chromosome  (VH)? 
Standard adaptive differentiation theories of VH-encoded products cannot be taking 
place in the system we have described because the H-2 haplotype of the I-J  + product 
is  irrelevant  in  the  cell  interaction.  Thus,  VH  cannot  have  learned  to  see  an  H-2 
haplotype that was not present during the cell's differentiative history. The same line 
of logic can be used to say that our results are unlikely to be due to the presence of 
contaminating anti-(anti-I-J)  antibodies in our anti-I-J sera.  Such antibodies would 
be influenced by the I-J haplotypes of the immunizing and/or antibody-producing 
cells  and thus would show an MHC linkage. YAMAUCHI ET AL.  663 
It  is  possible  that  some  product  of  the  17th chromosome  marked  by  the  I-J 
determinant can adaptively differentiate and become VH restricted. Although a short 
while ago this notion might have seemed far fetched at best, as we learn how little we 
know about gene rearrangement mechanisms (19), the possibility that prducts of one 
chromosome influence the expression of structural genes on chromosomes other than 
those known to contain variable regions (i.e.,  Ig loci) becomes less remote. 
A  more  conventional  explanation  of our  findings  would  be  that  I-J  encodes  a 
glycosyl transferase and that we are looking at a  12th chromosome gene product with 
a carbohydrate determined specificity given to it by an enzyme encoded on the  17th 
chromosome. 
The  most conventional  explanation  for the  data  (and  also  the  most  violative of 
Occam's Razor i.e., do not create more entities [read molecules] than are necessary for 
the explanation of a  phenomenon)  is that the I-J  + VH-restricting molecule is made 
of two separate polypeptides, and  the  biological function  of the  Ly-1  TsiF is thus 
dependent upon three separately encoded molecules (one that sees antigen; one that 
gives VH  restriction;  and  one that  is I-J  + and  of which  we do  not  know what  its 
function is or might be) that interact either directly or indirectly with one another. 
Lastly, we should comment on why we can mix an I-J filtrate with an I-J eluate 
from a noncellular extracted biologically active product and achieve activity, whereas 
other workers cannot. The simplest answer would be that our product is not a secreted 
one  but  is  released  by  dying  cells  in  culture.  This  would  then  make  our  results 
compatible with those of workers studying T  cell hybridomas (6,  7),  and thus there 
would be no contradictory evidence between laboratories (except for the differences 
in the finding of covalent linkage of the molecules in secreted factors by Taniguchi et 
al.).  It should,  however, be kept  in  mind  that  the  material we are studying comes 
from Ly-1 cells and shows VH-linked restriction.  None of the other studies  on I-J  ÷ 
material have shown that the material being studied comes from this T  cell subset or 
shows this restriction. It is well known that other T  cell subsets make I-J  + molecules, 
and  thus  the lack of molecular association of secreted  products may be dependent 
upon the nature of the cell that is making the product. In any case, the answer to this 
question  is  far  less  important  than  are  those  of how  the  I-J  +  material  gives  VH 
restriction and what the chemical nature of the VH-linked cell interaction structures 
is. Our present work is focused on answering these questions. 
Summary 
Immunized Ly-1 +2- T  cells (Ly-1 cells) make an antigen-specific soluble suppressor 
product  (Ly-1 TsiF)  that will  induce  Ly-2  + cells to express suppressive activity but 
only if the Ly-2  + cells and the Ly-1 producer cell share genetic polymorphisms that 
are linked  to the Igh locus and in particular that  part where the Igh-V (or VH)  is 
encoded. Ly-1 TsiF can be separated into two entities, one binds antigen and does not 
express I-J determinants, and the other is I-J  + and does not bind antigen. Neither of 
these "subfactors" has biological activity, but a  50:50 mixture of them reconstitutes 
biological activity that expresses the antigen specificity of the antigen-binding mole- 
cule.  Any of the three heterologous erythrocytes (antigens)  studied  can be used  for 
immunization  to  produce  the  I-J  ÷  nonantigen-binding  factor,  i.e.,  the  I-J  + moiety 
makes  no  contribution  to  the  factor's specificity.  It  does,  however,  determine  the 
intact factor's Igh-V linked restriction. Thus, the antigen combining site of the factor 664  MOLECULAR COMPOSITION  OF LY-1 T  SUPPRESSOR  INDUCER  FACTOR 
is irrelevant to the factor's Igh-V restriction but  crucial for its specificity. The  I-J  + 
molecule  does  not  bind  antigen  nor  influence  the  factor's  antigen  specificity but 
expresses the Igh-V polymorphism (or anti-Igh-V polymorphism) that is required .for 
the transmission of an inductive signal to the factor's Ly-2  + acceptor cell. 
Received  for publication 21 August 1981. 
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